Session V: Therapeutic and preventive manipulation of microbiata

09.00 - 10.30

Session chair: Kieran Tuohy, Fondazione Edmund Mach, Italy

09.00 - 09.45 Marco Soriani, GSK, Italy
Discovery of a novel E. coli mucinase inducing broadly protective antibodies able to impair in vivo colonization

09.45 - 10.30 Trevor Lawley, Welcome Trust Sanger Institute, United Kingdom
Designing bacterial medicines to treat intestinal diseases: the Clostridium difficile paradigme

(Continued) session V

11.00 - 12.30

11.00 - 11.45 Johan van Hylckama Vlieg, Chr. Hansen, Denmark
Towards the 3rd wave of probiotic and therapeutic microbes

11.45- 12.00 Lionel Rigottier-Gois, INRA, France
Effect of probiotic strains on intestinal carriage of vancomycin-resistant Enterococcus faecalis

12.00 - 12.15 Inga Sarand, Tallinn University of Technology, Estonia
Intestinal survival of probiotic bacteria administered in double-strain ice cream

12.15 - 12.30 Siegfrid Hapfelmeier, Universisty of Bern, Switzerland
In-vivo growth deficiency of fully D-alanine auxotrophic smooth E. coli provides a robust model of sterile live bacterial intestinal colonization

Session VI: Therapeutic and preventive manipulation of microbiota

14.30 - 15.15

Session Chair: Lorenza Putignani, Ospedale Bambino Gesù, Italy

14.30 - 15.15 Bernard Berger, Nestlé, Switzerland
Industrial applications of microbiome research

15.15 - 16.00 Kieran Tuohy, Fondazione Edmund Mach, Italy
Diet-microbe interactions in the gut - microbiome modulation for human health

(Continued) Session VI

16.30 - 18.00

16.30 - 16.45 Aleksandra Antosiak, Institute of Immunology and Experimental Therapy, Poland
The paralel analysis of short chain fatty acids (SCFA), products of intestinal bacteria metabolism, and chemical markers of endotoxin (LPS), indicators of an intestinal microbiome homeostasis

16.45 - 17.00 Anastasia Chrysovalantou Chatziioannou, Aristotle University of Thessaloniki, Greece
Optimization of rat fecal sample preparation for metabolomics analysis using NMR and GC-MS

17.00 - 18.00 Next steps - Translating microbiome research into intervention strategies

Moderators:

Claudio Donati, Fondazione Edmund Mach, Italy
Marco Soriani, GSK, Italy
Duccio Cavalieri, University of Florence, Italy

Panel:

Trevor Lawley, Welcome Trust Sanger Institute, United Kingdom
Johan Van Hylckama Vlieg, CHR Hansen AS, Denmark
Bernard Berger, Nestlé Research Centre, Switzerland
Kieran Tuohy, Fondazioned Edmund Mach, Italy